Gilead Sciences (GILD) Dividends Paid - Common (2009 - 2026)

Gilead Sciences (GILD) reported Dividends Paid - Common of $1.0 billion for Q1 2026, up 3.59% on a YoY basis from $1.0 billion in Q1 2025, and up 4.63% quarter-over-quarter from $994.0 million in Q4 2025.

Gilead Sciences (GILD) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Gilead Sciences has reported Dividends Paid - Common for 13 years, with the latest figure at $1.0 billion in Q1 2026.

  • For the quarter ending Q1 2026, Dividends Paid - Common rose 3.59% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $4.0 billion (up 2.39% YoY), and the FY2025 full-year result was $4.0 billion, up 2.17% from the prior year.
  • Dividends Paid - Common for Q1 2026 stood at $1.0 billion, up from $994.0 million in the prior quarter.
  • The five-year high for Dividends Paid - Common was $1.0 billion in Q1 2026, with the low at $931.0 million in Q4 2022.
  • Historically, Dividends Paid - Common has averaged $969.8 million across 5 years, with a median of $973.0 million in 2024.
  • Annual changes were most pronounced in 2022 — Dividends Paid - Common gained 4.14% — and 2024, when it advanced 1.14%.
  • Gilead Sciences' Dividends Paid - Common stood at $931.0 million in 2022, then advanced by 1.5% to $945.0 million in 2023, then advanced by 2.96% to $973.0 million in 2024, then climbed by 2.16% to $994.0 million in 2025, then rose by 4.63% to $1.0 billion in 2026.
  • The last three Dividends Paid - Common figures came in at $1.0 billion (Q1 2026), $994.0 million (Q4 2025), and $995.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -866.88 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 1.55 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 3.13 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 3.09 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 2.11 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 1.36 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.04 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 2.45 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 1.28 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.04 Bn
Mar 31, 2026 1.04 Bn
Dec 31, 2025 994.00 Mn
Dec 31, 2025 994.00 Mn
Sep 30, 2025 995.00 Mn
Sep 30, 2025 995.00 Mn
Jun 30, 2025 997.00 Mn
Jun 30, 2025 997.00 Mn
Mar 31, 2025 1.00 Bn
Mar 31, 2025 1.00 Bn
Dec 31, 2024 973.00 Mn
Dec 31, 2024 973.00 Mn
Sep 30, 2024 977.00 Mn
Sep 30, 2024 977.00 Mn
Jun 30, 2024 978.00 Mn
Jun 30, 2024 978.00 Mn
Mar 31, 2024 980.00 Mn
Mar 31, 2024 980.00 Mn
Dec 31, 2023 945.00 Mn
Dec 31, 2023 945.00 Mn